30results about How to "Satisfactory treatment" patented technology

A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more intracranial (IC) stimulating electrodes in accordance with treatment parameters. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.

A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators to control neurological state and prevent neurological signs and symptoms. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.

A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators, comprising intracranial (IC) stimulating electrodes and other actuators, in accordance with treatment parameters. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.

A multi-functional portable electro-medical device that is capable of providing muscle stimulation and interferential current stimulation. The multi-functional portable electro-medical device includes a multitude of safety features which are designed to prevent injury to the user while at the same time to ensure that the portable power electro-medical device is easy to use. The portable electro-medical device can be programmed to impart any combination of wave therapy to the patient.

Provided is a long life carbide end mill which can perform stable cutting in high-efficiency machining such as die machining and parts machining. A cutting method using such an end mill is also provided. When a certain wavy or nicked peripheral cutting edge is considered a reference peripheral cutting edge with reference phases in a pitch of the reference peripheral cutting edge, wherein the distance of each reference phase is an amount corresponding to a value obtained by dividing the pitch of the nicks or waveform of each peripheral cutting edge by the number of the cutting edges; and the phase of at least one of the remaining peripheral cutting edges is deviated in the direction of the tool axis from the corresponding reference phase by an amount corresponding to 5% or less (excluding 0%) of the pitch.

An automated vehicle wash system including vehicle wash equipment, a mechanical room and a control module, such as a control pod. The control pod is positioned outside the mechanical room and adjacent the vehicle was equipment so that an operator of the control pod can directly view the wash equipment as the operator adjusts controls of the control pod to precisely regulate materials, such as chemicals and other treatment liquids, delivered by the wash equipment to a vehicle as the vehicle passes along a path.

This ion implantation apparatus is provided with a holding devise which holds the wafer, and which turns it along its circumference. In addition to holding the wafer at a prescribed position, the ion implantation apparatus subjects the wafer to ion implantation in regions where there is partial overlap of its circumference. The holding devise turns and inclines the wafer, and also holds the wafer by three or more holding pins. The side face of the holding pin has an inversely tapered shape, and the multiple holding pins include a first holding pin whose protrusion amount is relatively small, and a second holding pin whose protrusion amount is relatively large. The holding pin which is on the upper side from the center of the wafer in the planar direction of the inclined wafer is the second holding pin, and the angle of inclination of the side face of the second holding pin at a position where ions are implanted into the wafer has an angular degree which is equal to or less than an angle of incidence of the ion beam relative to the wafer.

A Chinese medicine in the form of particles for treating psoriasis is prepared from 13 Chinese-medicinal materials including gypsum, rehmannia root, red peony root, scutellaria root, etc. Its preparing process is also disclosed.

Protozoal cyclic GMP dependent protein kinases have been isolated and cloned. These enzymes may be used in screening assays to identify potential antiprotozoal agents.

The present invention relates to a novel use of alarin derived from a splice variant of galanin-like peptide (GALP) RNA and thus having an amino acid sequence similar to that of galanin, with a therapeutic agent of uremia, and the therapeutic agents of uremia according to the present invention include alarin as the main ingredient.

The invention provides a linseed oil based external drug for infantile eczema. The linseed oil based external drug comprises a raw reagent A, a compatible reagent B and a raw reagent C, wherein the raw reagent A comprises the following component by weight: 1 part of fresh egg; the compatible reagent B comprises the following components: 8 to 13% of realgar, 8 to 12% of sulphur, 10 to 15% of dried alum, and 10 to 15% of plant soot; and the raw reagent C comprises the following component in percentage by mass based on the mass of the egg in the raw reagent A: 45 to 55% of linseed oil. The preparation method of the linseed oil based external drug comprises the following steps in sequence: grinding each component in compatible reagent B into powder; sequentially adding the powder to the raw reagent A; sealing and uniformly shaking; wrapping the egg through soil and sealing; burning the egg with the soil until carbonizing; cooling in the air; removing the soil housing; grinding the soil-removed material into fine powder; heating the raw reagent C; adding the heated raw reagent C to the fine powder under fire removing state; stirring uniformly; and cooling until reaching the room temperature, thus obtaining the linseed oil based external drug for infantile eczema. The linseed oil based external drug for infantile eczema is simple in prescription, simple and quick to manufacture, low in cost, convenient to use, free from toxic or side effect during external use, and short in cure cycle.